Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Methyltransferases are a diverse group of enzymes that catalyze the transfer of methyl groups to various substrates, including proteins, nucleic acids (DNA and RNA), small molecules, and natural products. This methylation process is fundamental in regulating biological processes such as gene expression, epigenetic modification, metabolism, and cellular signaling. They are classified based on structural features (Class I, II, III) or substrate specificity (protein, DNA/RNA, natural product). Most utilize S-adenosyl methionine (SAM) as a cofactor, employing an SN2-like mechanism for methyl transfer. Aberrant activity is linked to various diseases, making them important drug targets.
SN2-like direct transfer of a methyl group from S-adenosyl methionine (SAM) to an acceptor atom/group on the substrate, converting SAM to S-adenosyl homocysteine (SAH).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Methyltransferase (MTase).